155 related articles for article (PubMed ID: 22364200)
1. Melanocortin-1 receptor-mediated signalling pathways activated by NDP-MSH and HBD3 ligands.
Beaumont KA; Smit DJ; Liu YY; Chai E; Patel MP; Millhauser GL; Smith JJ; Alewood PF; Sturm RA
Pigment Cell Melanoma Res; 2012 May; 25(3):370-4. PubMed ID: 22364200
[TBL] [Abstract][Full Text] [Related]
2. Defining MC1R regulation in human melanocytes by its agonist α-melanocortin and antagonists agouti signaling protein and β-defensin 3.
Swope VB; Jameson JA; McFarland KL; Supp DM; Miller WE; McGraw DW; Patel MA; Nix MA; Millhauser GL; Babcock GF; Abdel-Malek ZA
J Invest Dermatol; 2012 Sep; 132(9):2255-62. PubMed ID: 22572817
[TBL] [Abstract][Full Text] [Related]
3. Molecular and functional analysis of human β-defensin 3 action at melanocortin receptors.
Nix MA; Kaelin CB; Ta T; Weis A; Morton GJ; Barsh GS; Millhauser GL
Chem Biol; 2013 Jun; 20(6):784-95. PubMed ID: 23790489
[TBL] [Abstract][Full Text] [Related]
4. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.
Herraiz C; Journé F; Abdel-Malek Z; Ghanem G; Jiménez-Cervantes C; García-Borrón JC
Mol Endocrinol; 2011 Jan; 25(1):138-56. PubMed ID: 21084381
[TBL] [Abstract][Full Text] [Related]
5. Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse melanocortin 1 receptors.
Sánchez-Más J; Guillo LA; Zanna P; Jiménez-Cervantes C; García-Borrón JC
Mol Endocrinol; 2005 Apr; 19(4):1035-48. PubMed ID: 15650023
[TBL] [Abstract][Full Text] [Related]
6. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes.
Abdel-Malek ZA; Scott MC; Furumura M; Lamoreux ML; Ollmann M; Barsh GS; Hearing VJ
J Cell Sci; 2001 Mar; 114(Pt 5):1019-24. PubMed ID: 11181184
[TBL] [Abstract][Full Text] [Related]
7. Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor.
Le Pape E; Wakamatsu K; Ito S; Wolber R; Hearing VJ
Pigment Cell Melanoma Res; 2008 Aug; 21(4):477-86. PubMed ID: 18627531
[TBL] [Abstract][Full Text] [Related]
8. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
9. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
Yang Y; Chen M; Ventro G; Harmon CM
Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
[TBL] [Abstract][Full Text] [Related]
10. Melanocytes expressing MC1R polymorphisms associated with red hair color have altered MSH-ligand activated pigmentary responses in coculture with keratinocytes.
Roberts DW; Newton RA; Leonard JH; Sturm RA
J Cell Physiol; 2008 May; 215(2):344-55. PubMed ID: 17960564
[TBL] [Abstract][Full Text] [Related]
11. Defining the Contribution of MC1R Physiological Ligands to ATR Phosphorylation at Ser435, a Predictor of DNA Repair in Melanocytes.
Jarrett SG; Wolf Horrell EM; Boulanger MC; D'Orazio JA
J Invest Dermatol; 2015 Dec; 135(12):3086-3095. PubMed ID: 26168232
[TBL] [Abstract][Full Text] [Related]
12. Agouti signalling protein is an inverse agonist to the wildtype and agonist to the melanic variant of the melanocortin-1 receptor in the grey squirrel (Sciurus carolinensis).
McRobie HR; King LM; Fanutti C; Symmons MF; Coussons PJ
FEBS Lett; 2014 Jun; 588(14):2335-43. PubMed ID: 24879893
[TBL] [Abstract][Full Text] [Related]
13. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
Mo XL; Tao YX
Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
[TBL] [Abstract][Full Text] [Related]
14. Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway.
Hida T; Wakamatsu K; Sviderskaya EV; Donkin AJ; Montoliu L; Lynn Lamoreux M; Yu B; Millhauser GL; Ito S; Barsh GS; Jimbow K; Bennett DC
Pigment Cell Melanoma Res; 2009 Oct; 22(5):623-34. PubMed ID: 19493315
[TBL] [Abstract][Full Text] [Related]
15. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.
Suzuki I; Tada A; Ollmann MM; Barsh GS; Im S; Lamoreux ML; Hearing VJ; Nordlund JJ; Abdel-Malek ZA
J Invest Dermatol; 1997 Jun; 108(6):838-42. PubMed ID: 9182807
[TBL] [Abstract][Full Text] [Related]
16. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
17. Regulation of melanocortin-1 receptor pharmacology by melanocortin receptor accessory protein 2 in orange-spotted grouper (Epinephelus coioides).
Ji LQ; Rao YZ; Zhang Y; Chen R; Tao YX
Gen Comp Endocrinol; 2020 Jan; 285():113291. PubMed ID: 31568758
[TBL] [Abstract][Full Text] [Related]
18. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
[TBL] [Abstract][Full Text] [Related]
19. Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways.
Doyle JR; Fortin JP; Beinborn M; Kopin AS
J Pharmacol Exp Ther; 2012 Aug; 342(2):318-26. PubMed ID: 22547573
[TBL] [Abstract][Full Text] [Related]
20. Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes.
Kadekaro AL; Chen J; Yang J; Chen S; Jameson J; Swope VB; Cheng T; Kadakia M; Abdel-Malek Z
Mol Cancer Res; 2012 Jun; 10(6):778-86. PubMed ID: 22622028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
